Just six years after the onset of the COVID-19 pandemic, global media attention has shifted to a new worry: hantavirus.
What’s causing the concern? There have been seven confirmed cases and three fatalities linked to this outbreak. Active exposure and contact tracing is ongoing, involving individuals from around a dozen countries, particularly related to cruise ship passengers and crew members. The timeline is troubling, as the symptoms can take weeks to surface, meaning that travelers might have unknowingly crossed borders while contagious.
What is hantavirus?
According to Dr. McCullough’s Substack, hantaviruses belong to the Hantaviridae family, and the primary human pathogenic types are categorized into genera like orthohantavirus. These rodent-borne viruses have been known to cause severe illnesses such as hantavirus pulmonary syndrome (HPS) in the Americas and renal hemorrhagic fever syndrome (HFRS) in Eurasia.
Symptoms of a hantavirus infection can include fever, extreme fatigue, muscle aches, abdominal pain, nausea, vomiting, and shortness of breath. Severe cases might lead to significant breathing difficulties requiring hospitalization. Typically, symptoms emerge two to four weeks post-exposure, but instances of symptoms occurring up to 40 days later have also been reported.
Specifically, the strain linked to the cruise ship has been identified as an “Andean” variant.
Upon laboratory testing of samples from the ship, the observed strains included the andes virus (Andean orthohantavirus), endemic to southern South America, particularly Argentina and Chile.
Should I be concerned?
What sets the Andes variant apart is its potential for human-to-human transmission. Given the close quarters on ships, along with shared air systems and the lengthy incubation period—which can last for weeks without symptoms—conditions for unnoticed, rapid virus spread are ideal.
Dr. Peter McCullough, a noted critic of pandemic responses, expressed worry over how authorities are handling the current outbreak.
He remarked, “During the pandemic, important public health agencies made significant missteps. Now, it appears we are facing the same situation with the MV Hondius hantavirus outbreak.”
There’s also a concern that the methods being implemented might inadvertently elevate the risk of spreading the infection.
“Aerosol transmission is a pressing issue when it’s trapped within ventilation or air recirculation systems,” he added.
This often-overlooked aspect is critical. The incubation period can drag on for as much as eight weeks. So, individuals may disembark from a ship, board a flight, return home, and only then start to feel unwell.
What actions can we take?
This latest potential pandemic brings forth numerous unsettling questions. For instance, why would a major pharmaceutical entity invest in a hantavirus vaccine development when these viruses typically don’t pose a widespread risk? Major companies tend to shy away from pouring resources into threats that exist primarily in theory.
Timing also raises questions. With midterm elections approaching, some speculate whether this is a calculated effort to instill fear in the population and potentially hinder certain political agendas.
There are still many unanswered questions. One thing is clear: trust in governments, big pharmaceutical companies, and global health authorities is shaky. Dr. McCullough emphasizes, “Individuals must take charge of their own biological safety.”
This proactive approach urges early preparation rather than panic.
Because timing truly matters when respiratory symptoms arise.
Antiviral medications are more effective when administered early.
Anti-inflammatory medications show their best results early as well.
Breathing therapy works best when started early.
Procrastination is your foe.
A lesson gleaned from the previous pandemic highlights the importance of early treatment.
Many families have taken to keeping an infectious disease emergency kit at hand.
Don’t wait for the next trend; neither should you. As news unfolds, supply shortages can occur, healthcare providers may become overwhelmed, and medications may be difficult to secure. When demand spikes, access tends to vanish quickly.
Having an infectious disease emergency kit on standby alleviates uncertainty. With medicines pre-ordered and ready for when symptoms first appear—when time is of the essence—there’s no need to navigate crowded clinics or worry about availability. This proactive stance differentiates between being responsive and being ready.
